Stay updated on Pembrolizumab Combo in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Lung Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page now shows recruitment status 'No longer looking for participants' and adds help sections such as How to Read a Study Record, Common Questions, and How to Join a Study. It also updates the Intervention/Treatment heading from the previous Interventions formatting and revises the page version to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-15T15:50:54.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The page shows a new revision: v3.5.5 instead of v3.5.4, indicating a software release. No substantive study details or user-facing content appear to have changed.
    Difference
    0.0%
    Check dated 2026-06-08T14:47:12.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a minor maintenance update to the ClinicalTrials.gov entry.
    Difference
    0.0%
    Check dated 2026-05-18T03:41:11.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page revision marker was updated from v3.5.2 to v3.5.3, indicating a new version of the ClinicalTrials.gov page template/software rather than a substantive change to the displayed study record.
    Difference
    0.0%
    Check dated 2026-04-26T13:37:48.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.5.2 added; Revision: v3.5.0 removed.
    Difference
    0.0%
    Check dated 2026-04-19T04:48:12.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page now displays the study results section and related publications, including primary and secondary outcomes and timing information.
    Difference
    0.0%
    Check dated 2026-03-28T13:55:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Lung Cancer Clinical Trial page.